Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 560 participants.
Also called NCT05527717
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 560 participants
- Sponsor
- Registry
-
NCT05527717
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Recruiting
Technical summary
Registry record NCT05527717. Randomized; no masking; primary purpose treatment. Start 2022-11-16 (actual); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator
- Acronym
- RESCUE-SHOCK
- Condition
- Cardiogenic Shock
- Condition
- Acute Myocardial Infarction
- Condition
- Multi Vessel Coronary Artery Disease
- Condition
- Extracorporeal Membrane Oxygenation
- Intervention (Procedure)
- Culprit lesion only PCI (percutaneous coronary intervention)
- Intervention (Procedure)
- Immediate multi-vessel PCI
- Lead sponsor
- Samsung Medical Center
Record details
- Record id
cardio:ct-nct05527717- Content hash
2651de94830306ab4a8e04e1159a438fc7d10fc0c2c75318e293864a3e42539d